author-photo

Rashmi Nair

26

Papers

76

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Abstract 1713: Novel, potent and orally bioavailable small molecule CD73 inhibitors for cancer immunotherapy

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Incidence and severity of postoperative pain following root canal treatment in nonvital pulps with hand and rotary instrumentation techniques in Chhattisgarh Population

2021 Journal of Pharmacy and Bioallied Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Field Research on Collective Victimization in the Indian Subcontinent: Challenges and Strategies for Navigation

2020
- Rashmi Nair
- Sramana Majumdar
Show All
- Source
- Cite
- Save
Citations (0)
The Impact of Emotional and Demographic Factors on Impulsive buying Behaviour of Adolescents in Bangalore, India

2019 Indian Journal of Economics and Development
- Rashmi Nair
Show All
- Source
- Cite
- Save
Citations (0)
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity

2019 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (13)
Abstract B006: Functional antagonism of VSIG8-mediated immune suppression by oral VISTA agents

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (3)
A COMPARATIVE STUDY OF SHEAR BOND STRENGTH OF SELF ADHERING FLOWABLE COMPOSITE WITH CONVENTIONAL FLOWABLE COMPOSITE TO DENTIN: AN IN VITRO STUDY

2018 International journal of scientific research
Show All
- Source
- Cite
- Save
Citations (0)
An in-vitro assessment of the residual antimicrobial effects and surface alterations of gutta-percha disinfected with four different solutions

2017 Journal of Dr. NTR University of Health Sciences
- Rashmi Nair
- Shweta Bandhe
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1650: Targeting CD47- SIRPα interaction by novel peptide-based antagonists

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 4861: Oral immune checkpoint antagonists targeting PD-L1/VISTA or PD-L1/Tim3 for cancer therapy

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (9)